Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
暂无分享,去创建一个
Ross S Berkowitz | Christopher P Crum | Judy E Garber | Michael J Callahan | R. Berkowitz | J. Garber | C. Feltmate | M. Muto | C. Crum | M. Callahan | J. Elvin | F. Medeiros | D. Kindelberger | Michael G Muto | Colleen M Feltmate | Julia A Elvin | Fabiola Medeiros | David W Kindelberger
[1] Rochelle L. Garcia,et al. Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations. , 2004, The American journal of surgical pathology.
[2] Christopher P Crum,et al. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome , 2006, The American journal of surgical pathology.
[3] M. Beattie,et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Colgan. Challenges in the Early Diagnosis and Staging of Fallopian-Tube Carcinomas Associated with BRCA Mutations , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[5] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[6] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[7] R. Berkowitz,et al. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.
[8] H. Mefford,et al. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. , 1997, American journal of human genetics.
[9] M. Muto,et al. Advances in the Recognition of Tubal Intraepithelial Carcinoma: Applications to Cancer Screening and the Pathogenesis of Ovarian Cancer , 2006, Advances in anatomic pathology.
[10] J. Niloff,et al. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] T. Colgan,et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. , 2006, Gynecologic oncology.
[12] B. Rosen,et al. Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status , 2001, The American journal of surgical pathology.
[13] J. Garber,et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube , 2007 .
[14] B. Karlan,et al. BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype? , 2005, Obstetrics and gynecology.
[15] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[16] Rochelle L. Garcia,et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. , 2001, Gynecologic oncology.
[17] P. V. van Diest,et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. , 2000, Gynecologic oncology.
[18] A. McEwen,et al. Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy. , 2004, Gynecologic oncology.
[19] Rochelle L. Garcia,et al. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. , 2006, American journal of obstetrics and gynecology.
[20] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[21] Rochelle L. Garcia,et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. , 2002, Gynecologic oncology.
[22] G. Wiesner,et al. Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report. , 2000, Gynecologic oncology.
[23] T. Rebbeck,et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Olufunmilayo I. Olopade,et al. Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation , 2006 .
[25] R. Knapp,et al. Unifocal origin of advanced human epithelial ovarian cancers. , 1992, Cancer research.
[26] S. Cannistra. Cancer of the ovary. , 1993, The New England journal of medicine.
[27] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[28] M. King,et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.